Cizzle Biotechnology Holdings PLC
LSE:CIZ

Watchlist Manager
Cizzle Biotechnology Holdings PLC Logo
Cizzle Biotechnology Holdings PLC
LSE:CIZ
Watchlist
Price: 1.32 GBX -8.97% Market Closed
Market Cap: £5.2m

Operating Margin

0%
Current
No historical data
Comparison unavailable

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
0%
=
£0
/
£0

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
0%
=
GBX0
/
£0

Peer Comparison

Country Company Market Cap Operating
Margin
UK
Cizzle Biotechnology Holdings PLC
LSE:CIZ
5.7m GBP
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.8B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
NL
argenx SE
XBRU:ARGX
43.2B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
46.1B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
274.9B CNY
Loading...
DE
BioNTech SE
NASDAQ:BNTX
28B USD
Loading...
DK
Genmab A/S
CSE:GMAB
127.8B DKK
Loading...
US
United Therapeutics Corp
NASDAQ:UTHR
20.1B USD
Loading...
US
Incyte Corp
NASDAQ:INCY
19.8B USD
Loading...
US
Revolution Medicines Inc
NASDAQ:RVMD
18.8B USD
Loading...

Market Distribution

Not Available
No Country distribution data available for this multiple

Cizzle Biotechnology Holdings PLC
Glance View

Market Cap
5.2m GBX
Industry
N/A

Cizzle Biotechnology Holdings Plc is a holding company, which is actively seeking for new investment opportunity. The Company’s proof-of-concept prototype test is based on the ability to detect a plasma biomarker, a variant of CIZ1 known as CIZ1B. CIZ1 is a cell nuclear protein involved in deoxyribonucleic acid (DNA) replication, and the targeted CIZ1B variant is correlated with early stage lung cancer. The company helps to reduce the need for repeated computed tomography (CT) scanning. The firm provides its product AZD1656 is treatment for COVID19 patients. AZD1656 is an immunomodulator which damps down the inflammatory response characteristic of coronavirus disease (COVID-19) infection, while enhancing the part of the immune response.

CIZ Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Back to Top